Toll Free: 1-888-928-9744

Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

Published: Oct, 2014 | Pages: 41 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Kuhnil Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kuhnil Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Kuhnil Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kuhnil Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Kuhnil Pharmaceutical Co., Ltd.'s pipeline products

Reasons to buy

- Evaluate Kuhnil Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Kuhnil Pharmaceutical Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Kuhnil Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Kuhnil Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kuhnil Pharmaceutical Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Kuhnil Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Kuhnil Pharmaceutical Co., Ltd. Snapshot 5
Kuhnil Pharmaceutical Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Kuhnil Pharmaceutical Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products Glance 12
Kuhnil Pharmaceutical Co., Ltd. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Kuhnil Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Kuhnil Pharmaceutical Co., Ltd. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Kuhnil Pharmaceutical Co., Ltd. - Drug Profiles 17
KI-0501 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
melatonin ER 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
nimotuzumab 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
KI-0503 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
KI-1102 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
KI-1104 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
KI-0801 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
KI-1002 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
KI-1003 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
KI-1007 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
KI-1101 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
KI-1103 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
KI-1105 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Analysis 33
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products by Target 33
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration 34
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type 35
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action 36
Kuhnil Pharmaceutical Co., Ltd. - Recent Pipeline Updates 37
Kuhnil Pharmaceutical Co., Ltd. - Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 40
Methodology 40
Coverage 40
Secondary Research 40
Primary Research 40
Expert Panel Validation 40
Contact Us 41
Disclaimer 41
List of Tables
Kuhnil Pharmaceutical Co., Ltd., Key Information 5
Kuhnil Pharmaceutical Co., Ltd., Key Facts 5
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014 7
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014 8
Kuhnil Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014 9
Kuhnil Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014 10
Kuhnil Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11
Kuhnil Pharmaceutical Co., Ltd. - Phase III, 2014 12
Kuhnil Pharmaceutical Co., Ltd. - Phase II, 2014 13
Kuhnil Pharmaceutical Co., Ltd. - Phase I, 2014 14
Kuhnil Pharmaceutical Co., Ltd. - Preclinical, 2014 15
Kuhnil Pharmaceutical Co., Ltd. - Discovery, 2014 16
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Target, 2014 33
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014 34
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014 35
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 36
Kuhnil Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2014 37
Kuhnil Pharmaceutical Co., Ltd., Other Locations 39 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify